Summary:
Click image to enlarge
This is a 6-month, double blind study to investigate the efficacy, safety and tolerability of an investigational medication as adjunctive therapy to antidepressants in adult subjects with Major Depressive Disorder.
Qualified Participants Must:
• Be between 18 to 64 years of age
•
Be currently depressed
•
Be currently taking an antidepressant
Qualified Participants May Receive:
- Compensation for time and travel will be given to those who qualify
- Study related laboratory tests and medical care